Rousselot secures US patent for Nextida GC

Darling Ingredients’ health brand Rousselot has strengthened its position in the metabolic‑health market after the US Patent and Trademark Office granted Patent No. US12636339 for Nextida GC, a first‑of‑its‑kind collagen peptide composition shown to support healthy post‑meal blood glucose levels.

The patent covers both the production process and the use of Nextida GC as a dietary supplement ingredient, marking a significant milestone for the company as demand accelerates for natural, non‑pharmaceutical solutions to metabolic wellbeing.

Randall C. Stuewe, chairman and CEO of Darling Ingredients, said the patent underscores the scientific credibility behind the innovation.

“This patent reinforces the scientific foundation behind Nextida GC and highlights Darling Ingredients’ ability to translate its collagen expertise into targeted health solutions,” he said. “As demand grows for natural, non‑pharmaceutical approaches to health and wellness, we are strengthening our leadership in collagen peptide health ingredients while building a broader pipeline of Nextida solutions.”

Nextida GC is formulated to support healthier after‑meal glucose responses, offering supplement brands a novel, collagen‑based approach to metabolic support. It forms part of Rousselot’s expanding Nextida portfolio, which is being developed to address distinct functional health needs through precision‑engineered collagen peptides.

The US patent adds to a growing list of global protections. Authorities in Australia (AU2023279850B2), Europe (EP4498839B1), Japan (JP7751755B2) and China (CN119212574B) have already granted patents, with further applications pending across Brazil, Canada, Colombia, Korea, Mexico, India and Peru. The breadth of international recognition reflects both the novelty of the ingredient and the rising strategic importance of collagen peptides in the global health‑and‑wellness sector.

With metabolic health emerging as one of the fastest‑growing supplement categories, Rousselot’s newly patented technology positions the company at the forefront of science‑backed nutritional solutions designed to meet consumer demand for natural, effective and clinically grounded products.